{"title":"偶发性T1aG1 (TNM 1987)前列腺癌的治疗。","authors":"M S Soloway, J E Altwein","doi":"10.1002/pros.2990210524","DOIUrl":null,"url":null,"abstract":"Each tumor cell in a low grade, latent prostate cancer is theoretically at risk for transformation into a cell which eventually produces a clinically manifest cancer. The transformation rate is variable but has been calculated to take roughly 7 years [ 13. The neoplasm may be detected sooner if surgery for BPH identifies this low grade, low volume malignancy. This report of a consensus seminar addresses some of the controversial areas in regard to stage T laG 1 prostate cancer.","PeriodicalId":77436,"journal":{"name":"The Prostate. Supplement","volume":"4 ","pages":"149-51"},"PeriodicalIF":0.0000,"publicationDate":"1992-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pros.2990210524","citationCount":"2","resultStr":"{\"title\":\"The management of incidental T1aG1 (TNM 1987) prostate cancer.\",\"authors\":\"M S Soloway, J E Altwein\",\"doi\":\"10.1002/pros.2990210524\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Each tumor cell in a low grade, latent prostate cancer is theoretically at risk for transformation into a cell which eventually produces a clinically manifest cancer. The transformation rate is variable but has been calculated to take roughly 7 years [ 13. The neoplasm may be detected sooner if surgery for BPH identifies this low grade, low volume malignancy. This report of a consensus seminar addresses some of the controversial areas in regard to stage T laG 1 prostate cancer.\",\"PeriodicalId\":77436,\"journal\":{\"name\":\"The Prostate. Supplement\",\"volume\":\"4 \",\"pages\":\"149-51\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/pros.2990210524\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Prostate. Supplement\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/pros.2990210524\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Prostate. Supplement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pros.2990210524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The management of incidental T1aG1 (TNM 1987) prostate cancer.
Each tumor cell in a low grade, latent prostate cancer is theoretically at risk for transformation into a cell which eventually produces a clinically manifest cancer. The transformation rate is variable but has been calculated to take roughly 7 years [ 13. The neoplasm may be detected sooner if surgery for BPH identifies this low grade, low volume malignancy. This report of a consensus seminar addresses some of the controversial areas in regard to stage T laG 1 prostate cancer.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
